U.S. flag

An official website of the United States government

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 57 books (236 items)

2.
Holland-Frei Cancer Medicine. 6th edition.

Holland-Frei Cancer Medicine. 6th edition.

Kufe DW, Pollock RE, Weichselbaum RR, et al., editors.

Hamilton (ON): BC Decker; 2003.

3.
StatPearls [Internet].

StatPearls [Internet].

Treasure Island (FL): StatPearls Publishing; 2024 Jan-.

5.
Sixteen-week versus standard eight-week prednisolone therapy for childhood nephrotic syndrome: the PREDNOS RCT.

Sixteen-week versus standard eight-week prednisolone therapy for childhood nephrotic syndrome: the PREDNOS RCT.

Webb NJA, Woolley RL, Lambe T, et al.

Southampton (UK): NIHR Journals Library; 2019 May. (Health Technology Assessment, No. 23.26.)

6.
Daily low-dose prednisolone to prevent relapse of steroid-sensitive nephrotic syndrome in children with an upper respiratory tract infection: PREDNOS2 RCT.

Daily low-dose prednisolone to prevent relapse of steroid-sensitive nephrotic syndrome in children with an upper respiratory tract infection: PREDNOS2 RCT.

Christian MT, Webb NJA, Woolley RL, et al.

Southampton (UK): NIHR Journals Library; 2022 Jan. (Health Technology Assessment, No. 26.3.)

7.
C. elegans II. 2nd edition.

C. elegans II. 2nd edition.

Riddle DL, Blumenthal T, Meyer BJ, et al., editors.

Cold Spring Harbor (NY): Cold Spring Harbor Laboratory Press; 1997.

8.
9.
Systematic review of treatments for atopic eczema.

Systematic review of treatments for atopic eczema.

Hoare C, Li Wan Po A, Williams H.

Southampton (UK): NIHR Journals Library; 2000 Dec. (Health Technology Assessment, No. 04.37.)

10.
DNA Mismatch Repair Deficiency Tumour Testing for Patients With Colorectal Cancer: A Health Technology Assessment [Internet].

DNA Mismatch Repair Deficiency Tumour Testing for Patients With Colorectal Cancer: A Health Technology Assessment [Internet].

Assasi N, Blackhouse G, Campbell K, et al.

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2016 Aug. (CADTH Optimal Use Report, No. 5.3b.)

11.
Drugs and Lactation Database (LactMed®) [Internet].

Drugs and Lactation Database (LactMed®) [Internet].

Bethesda (MD): National Institute of Child Health and Human Development; 2006-.

12.
Comparative Oncology.

Comparative Oncology.

Baba AI, Câtoi C.

Bucharest (RO): The Publishing House of the Romanian Academy; 2007.

13.
Disease Control Priorities in Developing Countries. 2nd edition.

Disease Control Priorities in Developing Countries. 2nd edition.

Jamison DT, Breman JG, Measham AR, et al., editors.

Washington (DC): The International Bank for Reconstruction and Development / The World Bank; New York: Oxford University Press; 2006.

15.
A National Cancer Clinical Trials System for the 21st Century: Reinvigorating the NCI Cooperative Group Program.

A National Cancer Clinical Trials System for the 21st Century: Reinvigorating the NCI Cooperative Group Program.

Institute of Medicine (US) Committee on Cancer Clinical Trials and the NCI Cooperative Group Program; Nass SJ, Moses HL, Mendelsohn J, editors.

Washington (DC): National Academies Press (US); 2010.

17.
Management options for moderate to severe acne – pairwise comparisons: Acne vulgaris: management: Evidence review F2.

Management options for moderate to severe acne – pairwise comparisons: Acne vulgaris: management: Evidence review F2.

National Guideline Alliance (UK).

London: National Institute for Health and Care Excellence (NICE); 2021 Jun. (NICE Guideline, No. 198.)

18.
Management options for mild to moderate acne – pairwise comparisons: Acne vulgaris: management: Evidence review E2.

Management options for mild to moderate acne – pairwise comparisons: Acne vulgaris: management: Evidence review E2.

National Guideline Alliance (UK).

London: National Institute for Health and Care Excellence (NICE); 2021 Jun. (NICE Guideline, No. 198.)

19.
Management options for moderate to severe acne – network meta-analyses: Acne vulgaris: management: Evidence review F1.

Management options for moderate to severe acne – network meta-analyses: Acne vulgaris: management: Evidence review F1.

National Guideline Alliance (UK).

London: National Institute for Health and Care Excellence (NICE); 2021 Jun. (NICE Guideline, No. 198.)

20.
Management options for mild to moderate acne – network meta-analyses: Acne vulgaris: management: Evidence review E1.

Management options for mild to moderate acne – network meta-analyses: Acne vulgaris: management: Evidence review E1.

National Guideline Alliance (UK).

London: National Institute for Health and Care Excellence (NICE); 2021 Jun. (NICE Guideline, No. 198.)

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Images search in Bookshelf

  • Figure 2

Search details

See more...

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...